Transcriptional Effects of Candidate COVID-19 Treatments on Cardiac Myocytes

INTRODUCTION: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has emerged as a major cause of morbidity and mortality worldwide, placing unprecedented pressure on healthcare. Cardiomyopathy is described in patients with severe COVID-19 and increasing evidence suggests...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakobi, Tobias, Groß, Julia, Cyganek, Lukas, Doroudgar, Shirin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170897/
https://www.ncbi.nlm.nih.gov/pubmed/35686037
http://dx.doi.org/10.3389/fcvm.2022.844441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170897/
https://www.ncbi.nlm.nih.gov/pubmed/35686037
http://dx.doi.org/10.3389/fcvm.2022.844441

Ejemplares similares